Genomics Startup 54Gene Secures $15 Million in Series A Funding

Pan-African genomics startup 54gene has closed a Series A round of $15 million, bringing the company’s total venture investment to $19.5 million after it secured $4.5 million seed funding in July. The latest round was led by Adjuvant Capital , a New York and San Francisco-based life sciences fund backed by the International Finance Corporation, Novartis, and the Bill & Melinda Gates Foundation.
The investment will allow the company to “scale operations in support of generating novel insights from human genetics research, which results in high-impact discoveries for improving human health through therapeutic development,” 54gene said in a press release Tuesday.
“There is enormous potential in expanding the reach of global drug and vaccine discovery by including more diverse populations in research efforts,” said Jenny Yip, Adjuvant Managing Partner.
The startup will also work towards accelerating discovery capabilities by improving operations in genetics, bioinformatics, preclinical, clinical and commercial programs, it added. “This funding comes at a historically meaningful time, allowing us to deliver global impact through continued investment in research and strategic partnerships with leaders in the biomedical industry,” Founder and CEO Dr. Abasi Ene-Obong said.
54gene was launched in January 2019 with the goal of addressing the huge gap the genomics market currently poses for Africa. As of 2018, less than three percent of the data used in Genome-wide Association Studies were of African ancestry and currently, less than one percent of global drug discovery occurs on the continent.
Located in Africa’s most populous country, Nigeria, and in the United States, 54gene aims to improve the development and availability of medical products that will prove beneficial to Africans and the wider global population. It currently works with over 300 researchers, clinicians, and geneticists across the continent and has built an African Biobank, a biorepository that stores biological samples to provide data for academic and development research.
The company has said it will further explore partnerships and opportunities for the co-development of drug targets and therapeutics as part of its next stage of growth. It expects to partner with pharmaceutical, medical device, and diagnostic companies for clinical programs in Africa, led by the newly-appointed Vice President of Clinical & Regulatory Affairs, Kemi Williams.
In addition to the Series A raise, 54gene has formed a Scientific Advisory Board, composed of global leaders in clinical genetics, bioinformatics, and data science. The new partnership “marks a significant evolution in the growth of our company,” said Ene-Obong. “In the coming months, we will be focusing on building a genomic resource that we hope will add significantly to global health, while also translating to the health benefits of patients in Africa.”
The investment round also included participation from Raba Capital , V8 Capital , Ingressive Capital , and follow-on investment from Y Combinator , Better Ventures , Fifty Years , KdT Ventures , Aera VC and Pioneer Fund .
Source: Ventures Africa
en
SOURCE :The Nigerian Voice (business)
http://www.bhelpoori.com/2013/12/19/the-ashes-aus-returns/ Racist Skank Adeline Bababikov has cheap rates – call/text for appt 303-949-0383 720-513-3865
high line pointe reviews
high line pointe review
high line pointe apartments
adeline bababikov
high line pointe denver
I have been absent for a while, but now I remember why I used to love this blog. Thank you, I’ll try and check back more frequently. How frequently you update your web site?
Hi, Neat post. There’s a problem along with your site in web explorer, could test this… IE still is the market chief and a huge section of people will pass over your great writing due to this problem.
There is certainly a great deal to learn about this topic. I love all the points you’ve made.|
I’m gone to convey my little brother, that he should also go to see this web site on regular basis to obtain updated from most up-to-date reports.|
Ahaa, its good dialogue on the topic of this article here at this blog, I have read all that, so now me also commenting at this place.|
Awesome post.|
Hi to all, the contents existing at this website are genuinely awesome for people knowledge, well, keep up the nice work fellows.|
Amazing blog! Is your theme custom made or did you download it from somewhere? A design like yours with a few simple tweeks would really make my blog jump out. Please let me know where you got your theme. Appreciate it|
You actually make it seem so easy with your presentation but I find this topic to be really something that I think I would never understand. It seems too complicated and extremely broad for me. I’m looking forward for your next post, I will try to get the hang of it!|
Today, considering the fast way of life that everyone leads, credit cards have a huge demand in the economy. Persons throughout every area are using the credit card and people who are not using the card have arranged to apply for 1. Thanks for discussing your ideas on credit cards. https://psoriasismedi.com treatments for psoriasis